Dr Ruth Travis

Molecular Epidemiologist

Ruth is a molecular epidemiologist working primarily on the hormonal, lifestyle and genetic determinants of cancer, with a particular focus on breast and prostate cancer. She leads several projects for the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group, which conducts pooled analyses of prospective data on biomarkers and prostate cancer risk. Ruth is also principal investigator of a study on the effects of shift work and circadian rhythms on cancer, funded by the Health and Safety Executive, and has published research on the association of melatonin in relation to breast cancer risk. She is involved in several working groups within EPIC-Europe, including the EPIC-prostate and EPIC-lymphoma working groups, and represents EPIC as a member of the international Breast and Prostate Cancer Cohort Consortium (BPC3) and PRACTICAL consortium. Ruth joined the Unit in 2001 and obtained a DPhil in cancer epidemiology in 2005.

Copyright © EPIC-Oxford